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SUMMARY 
Irish wolfhounds have the highest probability of death at a young age of all breeds, according 
to Swedish animal actuarial data. The breed is 29 times more likely to die from cardiac causes 
than the baseline breed. In European studies, dilated cardiomyopathy (DCM) is shown to be 
hereditary in Irish wolfhounds with a prevalence ranging from 24 – 43 %. Studies have also 
shown that the breed has an increased risk to die from tumors, musculoskeletal, gastrointestinal 
and respiratory diseases. Few studies describe respiratory diseases in Irish wolfhounds, but 
studies conducted in Australia and North America show that pneumonia has a high incidence 
in the breed and that several cases have a fatal outcome.  
The aim of this study was to study impact of different health issues on morbidity and mortality 
in Swedish Irish wolfhounds, with focus on DCM and pneumonia. Questionnaires were sent to 
owners of purebred Irish wolfhounds born during 2006 – 2008. A total of 100 questionnaires 
were completed resulting in an overall response rate of 36 %. The study population consisted 
of 49 males and 51 females and among those 72 dogs were dead and 28 dogs were still alive at 
the end of the study. 
The results from this study showed that the most common causes of death were tumors, heart 
disease and pneumonia. These findings are partly supported by previous studies. Our study 
revealed pneumonia as one of the most common causes of death, which has not been shown 
before. Sixteen percent of the dogs included in the study were affected by DCM. Percentage of 
dogs with pneumonia on at least one occasion during their lifetime was 37 % and a majority of 
them had recurrent episodes. DCM was more common in males than in females, however, the 
difference was not significant. No sex predisposition was found regarding pneumonia. 
This study showed that DCM and pneumonia are common in Irish wolfhounds in Sweden. 
Because these diagnoses also have been reported as the most common causes of death, they 
should be given attention in the course of improving the general health in the breed. Further 
research is warranted regarding etiology, diagnosis and different treatment regimens concerning 
respiratory disease in the breed.  
SAMMANFATTNING 
Enligt försäkringsstatistik har svenska irländska varghundar högre sannolikhet att dö vid yngre 
ålder jämfört med andra raser. De löper en 29 gånger högre risk att dö av hjärtsjukdom. 
Europeiska studier har visat att dilaterad kardiomyopati (DCM) är ärftligt i rasen och har en 
hög prevalens (24 – 43 %). Studier har också visat att irländska varghundar har en ökad risk att 
dö av tumörsjukdomar, sjukdomar i rörelseapparaten samt av gastrointestinala- eller 
respiratoriska sjukdomar. Få studier finns tillgängliga rörande lunginflammationer i rasen, men 
utländska studier har visat att incidensen sannolikt är hög och att sjukdomen kan ha en dödlig 
utgång. 
Målet med denna studie var att undersöka sjuklighet och dödlighet hos svenska irländska 
varghundar med särskild fokus på DCM och lunginflammation. Enkäter skickades ut till ägare 
av renrasiga irländska varghundar födda under åren 2006 – 2008. Totalt besvarades 100 enkäter 
vilket resulterade i en svarsfrekvens på 36 %. Studiepopulationen bestod av 49 hanar och 51 
tikar, varav 72 hundar var döda och 28 hundar fortfarande i livet vid studiens slut. 
Resultaten från denna studie visade att de vanligaste dödsorsakerna var tumörsjukdom, 
hjärtsjukdom och lunginflammation. Detta överensstämmer delvis med tidigare studier. Vår 
studie visade att lunginflammation var en av de vanligaste dödsorsakerna, vilket inte har visats 
tidigare. Av hundarna i studiepopulationen hade 16 % DCM. Andelen av hundarna som varit 
drabbade av lunginflammation vid minst ett tillfälle var 37 % och majoriteten av dessa hade 
återkommande episoder. DCM var vanligare hos hanar jämfört med hos tikar men skillnaden 
var ej signifikant. Gällande lunginflammation förelåg ingen tydlig könspredisposition. 
Denna studie visade att DCM och lunginflammation är vanligt hos irländska varghundar i 
Sverige. Eftersom dessa diagnoser också rapporterats vara några av de vanligaste 
dödsorsakerna, bör de uppmärksammas i arbetet med att förbättra hälsan i rasen. Ytterligare 
forskning kring respiratoriska sjukdomar i rasen behövs med avseende på etiologi, 
diagnosställande och olika behandlingsregimer.  
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INTRODUCTION 
Heart disease is the fourth most common cause of death in Swedish insured dogs (Bonnett et 
al., 2005). Egenvall et al. (2005) found that Irish wolfhounds had the highest probability of 
death by 5 years, 8 years and 10 years of age compared to all other breeds in the insurance 
database of over 350 000 insured Swedish dogs. Indeed, the probability of death by 10 years of 
age was as high as 91 % in Irish wolfhounds. Compared to baseline breeds, the breed was 29 
times more likely to die from cardiac causes. Mortality rate ratios concerning tumors and 
musculoskeletal disorders showed that Irish wolfhounds were also more likely to die of those 
causes compared to other breeds. Moreover, studies have shown a high incidence of pneumonia 
in the breed and respiratory disease has been reported a common cause of death (Fleming et al., 
2011; Greenwell & Brain, 2014) 
Dilated cardiomyopathy (DCM) is a common disease in European Irish wolfhounds (Vollmar, 
2000; Distl et al., 2007). Although the insurance data is a valuable source of information to 
characterize the general health situation and causes of death in specific breeds in Sweden, the 
resolution of the information is limited and the database does not include old dogs. The aim of 
this study was, therefore, to study impact of different health issues on morbidity and mortality 
in the breed with focus on DCM and pneumonia. The results from this study will hopefully be 
useful to further evaluate the need of a breeding program regarding heart disease and reveal 
other important health issues. Because many of the Irish wolfhounds have at least one foreign 
parent, this study may provide information about the overall population of Irish wolfhounds 
(Wink, T., Swedish Kennel Club, pers. communication, 2015).  
LITERATURE REVIEW 
The canine heart 
The heart is located in the center of the thoracic cavity and consists of two atria and two 
ventricles. From the left atrium oxygenated blood flows to the left ventricle and from there, by 
the aorta, blood flows throughout the body to distribute oxygen and nutrients. From the organs 
the blood transports carbon dioxide and waste products, and through the veins blood flows back 
to the heart entering the right atrium by the posterior and anterior vena cavae. Blood flows from 
the right atrium to the right ventricle and then to the lungs where the blood takes up oxygen and 
releases carbon dioxide. The blood then returns to the heart by the pulmonary veins, entering 
the left atrium. In order for the blood to flow in the right direction, valves are located between 
the atria and ventricles and between the ventricles and the major arteries leaving the heart (aorta 
and the pulmonary artery). The valves open and close depending on the hydrostatic pressure. 
The valve between the left atrium and left ventricle is called the bicuspid valve or the mitral 
valve and the valve between the right atrium and right ventricle is called the tricuspid valve. 
The blood volume pumped by the ventricles during one minute is called the cardiac output (CO) 
and is dependent on the heart rate and the blood volume pumped out of each ventricle during 
one contraction; the stroke volume (Sjaastad et al., 2010). 
The heart mainly consists of striated muscle cells and this part of the heart is called the 
myocardium. The muscle cells occur in two types: contractile cells and autorhythmic cells. 
Ninety-nine percent of the muscle cells are contractile cells, which depolarize secondary to 
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stimuli. As opposed to the contractile cells, the autorhythmic cells depolarize spontaneously 
and this occurs most rapidly in the sinoatrial node, which is a cluster of cells located in the right 
atrium functioning as the heart’s main pacemaker. From there, the action potential is propagated 
through the myocardium; generating a contraction, a heartbeat (Sjaastad et al., 2010). 
Congestive heart failure 
The heart can be affected by different pathological processes which may result in cardiac 
dysfunction, such as for example myopathies, valvular diseases and congenital heart diseases. 
To maintain adequate CO and systemic blood pressure in the presence of a dysfunctional heart, 
several compensatory mechanisms are available. The heart rate and the peripheral resistance 
increase. The myocardium may increase in mass, i.e. hypertrophy, and, in the case of cardiac 
volume overload, it may stretch which results in cardiac dilation. Up to a certain limit, cardiac 
muscle cell can stretch which will result in an increased stroke volume, but when dilation 
exceeds optimum for the cells, the stroke volume will instead decrease. This is known as the 
Frank Starling’s law (Sjaastad et al., 2010; Miller et al., 2012). Other compensatory 
mechanisms include increased blood volume and redistribution of blood to vital organs. These 
mechanisms can be sufficient to maintain CO even in severe heart disease. When CO decreases 
because of a gradual loss of pump function, the pulmonary and systemic venous and capillary 
pressures increase, which may lead to congestive heart failure (CHF). The reduced cardiac 
pump function leads to a tendency for a lowered blood pressure, which stimulates several 
neuroendocrine systems, such as the renin-angiotensin-aldosterone system (RAAS). This 
response is compensatory in nature and results in increased retention of sodium and water, 
which increase the extracellular fluid compartment, including the plasma volume. The increase 
in plasma volume results in higher workload for the already failing heart and excess of fluid 
accumulates in body cavities. In case of left-sided CHF fluid accumulates in the lungs or the 
thoracic cavity and in case of right-sided or bilateral CHF, hepatic congestion and ascites are 
observed (Miller et al., 2012).  
Clinical signs associated with CHF are tachycardia, weak arterial pulse, labored breathing due 
to fluid retention in the lungs or thoracic cavity, slow capillary refill time, ascites and hepatic 
congestion (Lombard, 1984; Tidholm & Jönsson, 1997). In Irish wolfhounds one of the leading 
signs in severe CHF is pleural effusion (Vollmar, 1999). 
Cardiomyopathy 
Cardiomyopathy is characterized by pathological changes, associated with cardiac dysfunction, 
in the myocardium. Cardiomyopathy is classified into four different groups by the WHO-ISFC 
task force: dilated, hypertrophic, restrictive cardiomyopathy and arrhythmogenic right 
ventricular cardiomyopathy (Richardson et al., 1996). Dilated cardiomyopathy is characterized 
by uni-or bilateral cardiac dilation and reduced systolic function. Hypertrophic cardiomyopathy 
is recognized by ventricular myocardial hypertrophy, which results in myocardial stiffness and 
impaired ventricular filling. Restrictive cardiomyopathy is characterized by comparably normal 
ventricular dimensions and wall thickness, but increased ventricular stiffness, which results in 
impaired ventricular filling. Arrhythmogenic right ventricular cardiomyopathy is characterized 
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by a fibrous fatty infiltration in the right ventricular wall, which results in clinical signs such as 
arrhythmias and sudden death (Richardson et al., 1996).  
Dilated cardiomyopathy 
Dilated cardiomyopathy is characterized by dilatation of the left ventricle or of both ventricles 
and thinning of the ventricular walls, which leads to cardiomegaly and decreased systolic 
function (Lombard, 1984; Sandusky et al., 1984; Richardson et al., 1996). Grossly all heart 
chambers show slight to moderate dilation, but in dogs examined by Janus et al. (2015) only 
the left ventricle showed significant dilation. When histologically examining the myocardium 
in dogs diagnosed with DCM, two types of histological changes have been described: attenuated 
wavy fibers and fatty infiltration degenerative type (Tidholm & Jönsson, 1997; Janus et al., 
2015). The fatty infiltration degenerative type is the predominating type in Dobermanns 
(Calvert et al., 1997a; Everett et al., 1999) while attenuated wavy fibers type is frequently seen 
in other medium, large and giant breeds (Sandusky et al., 1984; Tidholm et al., 1998 & 2000; 
Dambach et al., 1999). Genetic factors have been shown to influence the development of DCM 
in several breeds and the disease has been suggested to be inherited as an autosomal dominant 
trait in Newfoundland dogs, Dobermanns and Great Danes (Dukes-McEwan & Jackson, 2002; 
Meurs et al., 2007; Stephenson et al., 2012). In some studies, other modes of inheritance have 
been suggested such as an autosomal recessive trait in young Portuguese water dogs (Dambach 
et al., 1999) and an x-linked recessive trait in Great Danes (Meurs et al., 2001). However, dogs 
of atypical breeds may also develop DCM. The etiology in these cases is unidentified, but 
theories such as infectious organisms and nutritional imbalances have been brought forward or 
the disease is considered as idiopathic (Meurs, 2010). 
Clinical signs 
The most common clinical signs associated with DCM are dyspnea and cough (Tidholm et al., 
1997; Martin et al., 2009). Other common clinical signs are exercise intolerance, weakness, 
weight loss, reduced appetite, collapse and lethargy. During physical examination typical 
clinical findings are tachycardia, weak pulse, gallop sound, systolic heart murmur, pale mucous 
membranes and ascites (Tidholm & Jönsson, 1997; Brownlie & Cobb, 1999; Martin et al., 
2009). In the retrospective study by Tidholm and Jönsson (1997), the majority of dogs affected 
by DCM did not have a heart murmur, but of the dogs presented with a murmur (25 %), 78 % 
of the described murmurs were grade II-III/VI. Similar findings have been reported by Martin 
et al. (2009) where a majority of the recorded murmurs were grade I-III/VI. Vollmar (2000) 
found when examining Irish wolfhounds with DCM that mild to severe mitral or tricuspid valve 
regurgitation was present in most patients that had a noticeable enlarged left or right ventricle. 
Arrhythmias are common and atrial fibrillation is most frequently recorded in giant dogs. The 
second most common arrhythmia is ventricular premature complexes (VPCs) (Tidholm & 
Jönsson, 1997; Martin et al., 2009), which differs from some other breeds were DCM is 
common for example Boxer and Dobermann, where VPCs instead is the most common 
arrhythmia (Martin et al., 2009). 
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Diagnosis 
Complete medical history and physical examination should be performed in all dogs. The terms 
preclinical (occult) and clinical (overt) dilated cardiomyopathy are used to describe different 
stages of the disease. Preclinical DCM refers to individuals without clinical signs of heart 
disease but in which DCM is detected after thorough examination. Clinical DCM refers to the 
stage when clinical signs are apparent (Meurs, 2010). To be able to diagnose preclinical and 
clinical DCM, and to differentiate it from other heart diseases, echocardiography is useful 
because an echocardiographic examination can evaluate the anatomy and the function of the 
heart (Dukes-McEwan et al., 2003). Echocardiography makes it possible to diagnose DCM in 
individuals where no clinical signs are present, though repeated examinations may be necessary 
in some cases. It is also helpful to monitor the progression of the disease and evaluate the 
response to therapeutics (Vollmar, 1999).  
Many dogs affected by DCM have arrhythmias (Martin et al., 2009) and electrocardiography 
should be carried out to examine the presence and type of arrhythmia, because it can be an 
indicator for diagnosis of DCM in some breeds, and to evaluate the need for antiarrhythmic 
therapy (Brownlie & Cobb, 1999; Dukes-McEwan et al., 2003). In some breeds, for example 
Dobermann, a 24-hour ambulatory electrocardiogram (Holter recording) can be useful to 
identify dogs of high risk of DCM (Calvert et al., 2000). In case of suspected CHF, thoracic 
radiographs are useful to evaluate cardiomegaly and to diagnose pulmonary edema or pleural 
effusion as well as abdominal radiographs for diagnosis of ascites (Tidholm & Jönsson, 1997; 
Martin et al., 2009). For a definitive diagnosis it is recommended that deceased dogs with 
diagnosis or suspicion of DCM should be examined post mortem (Dukes-McEwan et al., 2003).  
Prognosis 
Generally the disease progresses quickly and overall prognosis is poor, however, a difference 
in progression is seen between breeds (Calvert et al., 1997b; Dambach et al., 1999; Brownlie 
& Cobb, 1999). Death occurs due to CHF or dogs can die suddenly without signs of CHF 
(Tidholm et al., 1997; Janus et al., 2015). A study of different breeds by Martin et al. (2009) 
showed that median duration of signs before referral was three weeks and by then the majority 
of the dogs had clinical signs of CHF. That study also showed that median survival time after 
referral in dogs with DCM was 19 weeks and the survival rate was found to be 28 % at one year 
and 14 % at two years from referral. A survival analysis on different breeds by Monnet et al. 
(1995) showed that there was a 50 % probability of survival 2,3 months after diagnosis had 
been made. At one and two years from diagnosis the probability of survival was 38 % and 28 
%, respectively. In another study survival rates in dogs of different breeds with CHF caused by 
DCM were found to be 18 % at one year and 8 % at two years from time of initial diagnosis 
(Tidholm et al., 1997). The effect of different cardiac therapies was not evaluated in the survival 
studies and more recent studies have shown a significantly increased lifespan when dogs 
affected by DCM have been treated with Pimobendan compared to those who have not received 
the drug (Fuentes et al., 2002; O’Grady et al., 2008). Poor prognostic indicators in DCM were 
presence of pleural effusion or pulmonary edema, young age at onset of clinical signs, dyspnea 
and ascites (Monnet et al., 1995; Tidholm et al., 1997). Some echocardiographic measurements 
of cardiac size and motion have also been shown to be predictive of outcome (Borgarelli et al., 
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2006). Menaut et al. (2005) showed that dogs with atrial fibrillation without structural or 
functional heart disease had longer survival time compared to dogs with atrial fibrillation and 
structural heart disease or CHF.  
Dilated cardiomyopathy in Irish wolfhounds 
Irish wolfhounds have the highest mortality rate ratio regarding heart disease of all Swedish 
breeds, with a 29 times increased risk of death due to cardiac causes (Egenvall et al., 2005). In 
a retrospective study including 500 Irish wolfhounds examined at a veterinary hospital in 
Germany, cardiovascular abnormalities were noted in 42 % and DCM was diagnosed in 24 % 
of the dogs. Affected dogs had a mean age of 4,2 years (Vollmar, 2000). In a study by Distl et 
al. (2007) the prevalence of DCM was 26 % and a more recent study by Vollmar et al. (2013) 
showed that 43 % of the Irish wolfhounds had DCM, the mean age for affected dogs in those 
studies were 4,4 years and median age 4,3 years, respectively. Philipp et al. (2012) found in 
their study that mean age of diagnosis of DCM in dogs from Europe was 4,9 years. Brownlie 
and Cobb (1999) found that the mean age at which CHF had developed in British Irish 
wolfhounds was 6,4 years in males and 7,2 years in females. Time from detection of heart 
disease to development of CHF in Irish wolfhound was very variable but was in that study 27 
months in males and 24 months in females. Swedish insurance data has shown that median age 
at death of Irish wolfhounds with cardiac disease was 7,5 years (Egenvall et al., 2006).  
In the publication by Brownlie and Cobb (1999) 12 % of the Irish wolfhounds without clinical 
sign of heart disease had atrial fibrillation. Among dogs with DCM, 46 % had atrial fibrillation 
diagnosed at their first examination and by the time these individuals had developed CHF, all 
dogs suffered from atrial fibrillation. The authors, therefore, proposed that atrial fibrillation 
may be an indicator of preclinical DCM in Irish wolfhounds. Vollmar (2000) found that out of 
121 Irish wolfhounds with DCM, 88 % had atrial fibrillation and 11 % had VPCs. Likewise, 
Martin et al. (2009) found atrial fibrillation in 94 % of Irish wolfhounds with DCM. 
In a study performed to evaluate the prevalence of whole blood taurine deficiency in Irish 
wolfhounds with and without DCM, there was no association between occurrence of DCM and 
low taurine levels in the blood, based on measurements from one occasion (Vollmar et al., 
2013). 
Inheritance 
Distl et al. (2007) showed that males were affected by DCM significantly more often than 
females and Brownlie and Cobb (1999) found a trend of males being affected at a younger age 
compared to females. In a study performed to analyze the mode of inheritance regarding DCM 
in Irish wolfhounds Distl et al. (2007) found that a major gene model with a sex-dependent 
allele effect was most probable. They suggested that development of DCM can be attributed to 
a single gene locus and further polygenic effects. Philipp et al. (2012) also found that multiple 
loci potentially were associated with DCM in Irish wolfhounds.  
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Other health issues in Irish wolfhounds 
The median age at time of death for British Irish wolfhounds was 6,2 years and mean age at 
time of death for Irish wolfhounds studied in Norway was 7 years (Michell, 1999; Anfinsen et 
al., 2011). Swedish Irish wolfhounds have a 91 % probability of death at an age of 10 years 
(Egenvall et al., 2005). Egenvall et al. (2005) also showed that Irish wolfhounds had an 8,9 
times increased risk to die from tumors and 6,7 times increased risk to die from musculoskeletal 
disorders compared to baseline breeds, which place them among the breeds with the highest 
mortality rate ratios in these categories. This shows that, in addition to heart disease, there are 
also other diseases that are major contributors to the high overall mortality rate in the breed. 
Bonnett et al. (2005) presented that death due to heart disease accounted for 25 % of all deaths 
in the breed and death due to tumors accounted for 22 %. In North American Irish wolfhounds, 
the most common organ system registered for cause of death was musculoskeletal (22 %) and 
the breed was one of the top five breeds with musculoskeletal causes of death (Fleming et al., 
2011). Other common organ systems listed as cause of death were gastrointestinal (15 %), 
cardiovascular (13 %) and respiratory (12 %). When cause of death was categorized by 
pathological diagnosis, the most common cause in Irish wolfhounds was neoplastic disease, 
which accounted for 32 % of the deaths among these categories except for unclassified (36%). 
Likewise, in a survey performed on British dogs of different breeds, Irish wolfhounds were 
over-represented regarding tumors as cause of death (Michell, 1999). 
Osteosarcoma 
Osteosarcoma was the most frequently occurring bone tumor in dogs of different breeds and 
was likely to occur in large breed middle-aged dogs in the study by Liu et al. (1977). The risk 
of osteosarcoma has been shown to rise with increasing body weight, height and age, although 
a hereditary etiology in individual breeds could not be excluded (Ru et al., 1998). In that study, 
Irish wolfhounds were shown to have an odds ratio of 20,7 for osteosarcoma, and thereby the 
highest risk of osteosarcoma of all included breeds. Swedish Irish wolfhounds had the highest 
incidence rate of all breeds regarding malignant bone tumors with an incidence rate of 99 cases 
per 10 000 dog-years at risk, based upon insurance data. The overall incidence rate was 5,5 
cases per 10 000 dog-years at risk. The top five breeds at risk were all large or giant breeds 
(Irish wolfhound, St. Bernard, Leonberger, Great Dane and Rottweiler). Up to 10 years of age 
12 % of the Swedish Irish wolfhounds were estimated to have developed malignant bone tumors 
based on 23 affected dogs (Egenvall et al., 2007). In a retrospective population-based survey in 
Norway, Irish wolfhound had the highest incidence rate of primary bone tumors of the four 
breeds included, with a rate of 126 cases per 10 000 dog-years at risk (Anfinsen et al., 2011). 
Most of the osteosarcomas originate in the appendicular skeleton (Liu et al, 1977; Anfinsen et 
al., 2011; Egenvall et al., 2007). Clinical signs associated with osteosarcomas in the extremities 
are lameness, pain and swelling over the lesion (Liu et al., 1977). 
Pneumonia 
A study describing 28 Irish wolfhounds from Europe and North America with clinical signs of 
rhinitis and bronchopneumonia showed that the majority of affected dogs had clinical signs 
present since birth (Clercx et al., 2003). Common signs were intermittent or persistent mucoid 
or purulent nasal discharge, cough and dyspnea. In some of the dogs, recurrent acute episodes 
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of bronchopneumonia were present. Antibiotic treatment resulted in a positive response, but in 
several cases regular periodic treatment, or even continuous treatment, was required. Four of 
the dogs died at an age under 14 months due to severe pneumonia. Pedigree analysis of the dogs 
from Europe and Canada revealed that ancestors were shared, which according to the authors, 
suggests a heritable syndrome. Primary ciliary dyskinesia or primary immunodeficiency were 
not detected among the affected dogs and signs of heart disease were also absent.  The rhinitis 
and bronchopneumonia syndrome described above was first reported by Wilkinson (1969). 
Wilkinson (1969) pointed out that the condition was well distributed through the breed and 
rather suggested the etiology to be a viral infection with secondary bacterial invasion. Different 
bacterial organisms were found in nasal discharge from affected puppies but healthy puppies 
did not develop infection when exposed to infected nasal discharge. In the majority of the cases, 
puppies from the same litters as the affected puppies remained healthy even though the lived in 
close contact with each other. A case report of three related Irish wolfhounds less than one year 
of age with clinical signs of respiratory disease instead indicated a primary cell-mediated 
immunodeficiency (Leisewitz et al., 1997). In a more recent study, a retrospective analysis of 
medical records determining the incidence of pneumonia in dogs admitted to a veterinary 
hospital in Sydney during 2008 – 2012, Irish wolfhound had the highest incidence of all breeds 
based on 25 Irish wolfhounds. However, four of the affected Irish wolfhounds had a 
predisposing cause for aspiration pneumonia identified such as laryngeal paralysis, a choking 
episode and gastric dilation (Greenwell & Brain, 2014). 
Other diseases 
Gastric dilation volvulus has been seen with a higher incidence in some giant and large breed 
dogs, among them Irish wolfhounds, and the incidence increased with increasing age (Glickman 
et al., 2000). Other known health issues in Irish wolfhounds are intrahepatic portosystemic 
shunts where an incidence of 3,4 % was reported when screening puppies in United Kingdom 
(Kerr & van Doorn, 1999). This disorder is likely hereditary (van Steenbeek et al., 2009). 
Furthermore, Casal et al. (2006) described epilepsy to be hereditary in Irish wolfhounds with 
an incidence of 18 % among 120 related litters, however, neurological causes have not been 
reported as a common cause of death in the breed in Sweden (Egenvall et al., 2005). Regarding 
developmental orthopedic diseases, LaFond et al. (2002) found that Irish wolfhounds had an 
increased risk for fragmented coronoid process, osteochondrosis in the stifle and in the shoulder 
and panosteitis, compared to mixed-breed dogs. Krontveit et al. (2010) found that the estimated 
incidence risk of hip dysplasia was 10 % in Irish wolfhounds which was the lowest incidence 
risk compared to the three other breeds included in the study. 
MATERIAL AND METHODS 
Study design 
A retrospective study was performed by distributing a questionnaire to owners of purebred Irish 
wolfhounds born between January 1st 2006 and December 31st 2008 registered in the Swedish 
Kennel Club (SKK). These years were chosen because the dogs would have reached an age of 
7-9 years, and possibly be affected by diseases, for example DCM. Furthermore, a majority of 
them would not be alive, which allows a possibility to study causes of death (Egenvall et al., 
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2005; 2006). Moreover, the range of year of birth was chosen so that, in cases of death, this 
would not have occurred too long ago, which means that the owners may remember the details. 
The questionnaire was sent by mail to all owners where an address was available in the SKK’s 
register, in total, 280 questionnaires were sent to 232 owners. Recipients that had not responded 
by the time required received one reminder. Reminding notices were also published at the 
webpage and the Facebook page of the Swedish Irish Wolfhound Club.  
The questionnaire was divided into three sections, where the first consisted of questions 
regarding general information such as sex, number of identification, neutering status, weight, 
coat color, breeding history and the owners contact information. The first section was for 
everyone to answer. Moreover, the questionnaire was divided into one section for dogs that 
were dead and one section for dogs that were still alive. These sections contained questions 
about cause of death, time of death, a potential history of DCM, clinical signs observed by the 
owner and potential ongoing medical treatments. Questions were also asked about history of 
pneumonia, if and how they were treated, if they were recurrent, and if known relatives were 
affected. In this study, relatives were defined as mother, father, siblings and offspring. 
Furthermore, in the section for the dogs that were still alive more specific questions were asked 
whether heart and thorax of the dog had been examined by a veterinarian. The information from 
the questionnaires was treated completely anonymously and permission was asked for access 
to veterinary records if considered required. A translated English version of the questionnaire 
is attached in Appendix 1.  
Data management 
The information from the questionnaires was entered into a Microsoft Excel document.  
Information about causes of death was divided into different main classes, which was used in 
the questionnaire. Complete and correct birth date was controlled for each dogs in the SKK’s 
register as well as sex and coat color.  
Information about clinical signs and results from examinations, that were associated with heart 
disease, were evaluated by the author to determine whether the dog in this study was to be 
classified to be affected by DCM or not. Dogs that had the diagnosis DCM based on clinical 
and echocardiographic examinations were classified as having DCM. Dogs with clinical signs 
such as atrial fibrillation, heart murmur and developing CHF were classified as being probably 
affected by DCM and dogs with CHF at time of euthanasia with no prior clinical signs were 
classified with suspicion of DCM. All these dogs were later included when calculating 
occurrence of DCM. Concerning frequencies of pneumonia, questions were not asked about 
how the dog had been diagnosed, but only if it had been affected by pneumonia on at least one 
occasion during the dog’s lifetime.  
Statistical analyses 
Basic descriptive statistics was used to examine the study population regarding dog 
characteristics, causes of death and occurrence of diagnoses such as DCM and pneumonia. If 
owners had reported multiple causes of death for one dog, each diagnosis was accounted for in 
the statistical analysis. To test the hypotheses of difference in occurrence of DCM and 
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pneumonia between sexes, Fisher’s exact test was used. This test was chosen because it is 
appropriate when sample sizes are small. Level of statistical significance was set to p < 0,05. 
The statistical analyses were carried out with a commercially available statistical software 
programa.   
RESULTS 
During the years 2006 – 2008, 460 purebred Irish wolfhounds were born and registered in the 
SKK register. Of the 280 distributed questionnaires, 100 were completed and returned by mail 
to the Swedish University of Agricultural Sciences. Four letters were returned due to unknown 
recipients. This resulted in a total response rate of 36 %. Not all owners answered all the 
questions in the questionnaire, resulting in varying response rates for different variables in the 
calculations. The study population consisted of 49 males and 51 females. Summary statistics 
for the dogs included in the study are presented in Table 1.  
Table 1. Dog characteristics, number of dogs with dilated cardiomyopathy (DCM) 
and number of dogs with pneumonia, presented for dogs born in 2006, 2007 and 
2008, respectively 
Group 2006 2007 2008 
Number of dogs 42 37 21 
Response rate 39 % 38 % 30 % 
Alive/dead 9/33 (42) 10/27 (37) 9/12 (21) 
Sex, male/female 22/20 (42) 18/19 (37) 9/12 (21) 
Weight (kg) 69 (35) 67 (35) 68 (19) 
Neutered 4 (38) 8 (34) 5 (20) 
Coat color, 
B/RB/DB/F/W/Bl 
25/1/0/3/6/7 
(42) 
26/2/1/4/2/2 
(37) 
16/0/1/1/1/2 
(21) 
Number 
with offspring 
6 (42) 5 (36) 5 (20) 
DCM 8 (42) 6 (37) 2 (21) 
Pneumonia 13 (36) 14 (34) 6 (19) 
Summary of dog characteristics. Weight is given as mean weight in kilograms, coat color 
brindle (B), redbrindle (RB), dark brindle (DB), fawn (F), wheaten (W) and black (Bl). 
Total number of values for each specific category is presented in parenthesis. Dogs that 
had been diagnosed with both DCM and pneumonia appear in both disease groups.   
Cause of death 
Of the 100 dogs included in the study, 72 dogs were dead. Twelve owners had reported multiple 
causes of death for the dog, which were all accounted for in the statistical analysis. The most 
common cause of death was tumors, heart disease and pneumonia (Figure 1). Tumors accounted 
for 24 % of the causes of death, where osteosarcoma and other tumors represented 9 % and 15 
%, respectively. The proportion of heart disease consisted of dogs classified to have DCM, 16 
                                                 
a JMP Pro v. 11.2.0, Cary, NC, USA. 
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%, and unclassified heart diseases, 1 %.  The largest proportion of cause of death was 
represented by other causes of death which included dogs that had died due to gastric dilation 
volvulus 7 % (6 dogs), megaesophagus 3 % (3 dogs), paresis 3 % (3 dogs), epilepsy 2 % (2 
dogs), pyometra 2 % (2 dogs), kidney disease 2 % (2 dogs), osteomyelitis or septic arthritis 2 
% (2 dogs), diabetes mellitus 1 % (1 dog), traffic accident 1 % (1 dog), intoxication 1 % (1 
dog), behavioral issues 1 % (1 dog), stiffness of the neck 1 % (1 dog), lethargy 1 % (1 dog) and 
old age 1 % (1 dog).  
 
Figure 1. Proportional mortality in 72 Irish 
wolfhounds. 
Of the deceased dogs, all but 5 dogs had been euthanized. The remaining 5 dogs had died 
suddenly, which result in a sudden death rate of 7 %. One of these dogs had undergone a post 
mortem examination and was diagnosed with acute circulatory failure with a strong suspicion 
of DCM. One other dog was diagnosed with DCM prior to sudden death, and in the other dogs 
the owners suspected gastric dilation volvulus in one case, and simply old age in another. There 
was one dog, which had died suddenly, where no specific disease was suspected as cause of 
death.  
Dilated cardiomyopathy 
Overall occurrence of DCM in the study was 16 % (16 dogs) based on 100 completed 
questionnaires. A majority of these dogs had either been diagnosed with DCM by an 
echocardiographic examination, or by post mortem examination (75 %). The other dogs were 
classified by the author as being probably affected by DCM, or with a strong suspicion of DCM 
based on presence of atrial fibrillation and/or clinical signs suggestive of CHF. The proportion 
of dogs affected by DCM are shown, divided by sex, in Figure 2. There was no significant 
difference in occurrence of DCM between sexes (p = 0,28). 
Heart disease
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Figure 2. Proportion of dogs with dilated cardiomyopathy by sex, based on 
data from 49 males and 51 females. The difference between sexes was not 
significant.  
Pneumonia 
The total proportion, where the owners had answered that the dog had pneumonia on at least 
one occasion, was 37 % (33 dogs). Number of values for this question were 89 answers. The 
proportions of dogs with at least one episode of pneumonia presented by sex are shown in 
Figure 3. There was no significant difference in occurrence of pneumonia between sexes (p = 
0,83). 
 
Figure 3. Proportion of dogs with at least one episode of pneumonia by sex, 
based on data from 45 males and 44 females. The difference between sexes 
was not significant. 
Among the dogs with a history of pneumonia, all 33 owners had answered the question 
regarding recurrence. Eighteen dogs had recurrent episodes of pneumonia and 11 of them had 
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pneumonia three times or more. Two dogs had developed pneumonia up to 14 times during 
their lifetimes. The proportions of dogs with only one episode of pneumonia and dogs with 
recurrent pneumonias are shown in Figure 4.  
 
Figure 4. Proportion of dogs with a history of only one episode of 
pneumonia and dogs with recurrent episodes of pneumonia. 
Among the 33 dogs with at least one episode of pneumonia, 16 % (5 dogs) had also been 
diagnosed with DCM. Among those, one dog had pneumonia a total of 14 times during its 
lifetime. In 3 of the 33 dogs, the owners had reported other concurrent disease, such as 
megaesophagus. Of the deceased dogs (27), with at least one episode of pneumonia, 52 % had 
pneumonia listed as a cause of death. 
DISCUSSION 
The study population included purebred Irish wolfhounds born during 2006 – 2008. Dogs fitting 
these criteria were 460 dogs, but for 180 dogs no contact information was available and 
therefore these dogs were not included. Only a minority of the dogs born during these years 
compose the study population, and results from this study may not entirely be representable for 
the general Swedish Irish wolfhound population. However, there were no indications that dogs 
whose owners not had reported their contact information to the SKK, would be more or less 
affected by diseases than the others, and, thus, not introducing a systematical error. The survey 
had a response rate of 36 % consisting of 100 dogs, which may provide valuable information 
from a comparably large group of Irish wolfhounds. The response rate in this study is 
comparable to other studies with a similar study design, such as Mandigers et al. (2006), which 
had a response rate of 37 %. Other similar studies, with small differences in study design, have 
reached response rates of 21 % (Proschowsky et al., 2003), 36 % (De Risio et al., 2015) and 51 
% (Anfinsen et al., 2011), which suggests the response rate in this study to be reasonable. 
Because 43 % of the Swedish Irish wolfhounds born during 2006 – 2008 had at least one foreign 
parent (Wink, T., Swedish Kennel Club, pers. communication, 2015), this study may also 
provide some information about the overall population of Irish wolfhounds. Most common 
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countries the parents came from during these selected years were Sweden, Great Britain, Italy 
and from other Scandinavian countries. The years were specifically chosen to allow studies of 
morbidity and mortality, because the dogs had reached an age where many events may have 
occurred, but not too far back in time for the owner to forget details of their dog’s health 
situation. The latter represents one important limitation with retrospective survey studies, 
because important details about clinical signs, cause of death and time of death might have been 
forgotten or mixed up with other dogs in the household. When a retrospective survey is 
performed, information concerning clinical signs and diagnoses are based on the owners’ 
perceptions and knowledge about type of examinations that were performed. Naturally, this is 
very dependent on how good the communication between owner and veterinarian has been. For 
example, this means that dogs with preclinical stages of DCM will be undiscovered unless the 
owner has brought the dog to the veterinarian for heart evaluation. However, an advantage with 
a survey compared to clinical case series including dogs visiting veterinary hospitals, is that the 
results will not be skewed by selection bias. Dogs attending veterinary clinics are more likely 
to have disease, which would lead to higher prevalence of disease. The information from the 
questionnaire was treated completely anonymously, which means that owners could share 
information about their dogs without risking this information to be spread to others.  
Cause of death 
Only two of the deceased dogs had undergone a post mortem examination, which means that 
causes of death were determined with different degrees of certainty for the dogs. The results 
from this study with tumors, heart disease and pneumonia as the most common causes of death, 
are partly supported by previous studies based on Swedish insurance data by Egenvall et al. 
(2005) and Bonnett et al. (2005), where the breed was found to have an increased cause specific 
mortality rate for heart disease and tumors. Other studies have also reported neoplastic disease 
to be over-represented as cause of death in the breed (Michell, 1999; Fleming et al., 2011). In 
this study osteosarcoma accounted for a large portion of all the tumors, and other studies have 
also shown bone tumors to be a common cause of death (Egenvall et al., 2007; Anfinsen et al., 
2011). Furthermore, Egenvall et al. (2005) and Fleming et al. (2011) found that musculoskeletal 
disorders were reported as a common cause of death in Irish wolfhounds. In the study by 
Egenvall et al. (2005), osteosarcoma was not included in this category, but in the study by 
Fleming et al. (2011) the category included all diseases localized to the specific organ system 
which allowed tumors such as osteosarcoma to be included. Regarding other musculoskeletal 
disorders, for example hip dysplasia, a low incidence has been shown in the breed (Krontveit 
et al., 2010). In our study, joint disease only accounted for 5 % of the deaths. However, some 
owners reported other causes of death, which cannot with certainty be distinguished from 
musculoskeletal or neurological disorders, for example paresis (3 %) and stiffness of the neck 
(1 %). Previous studies have shown diseases in the gastrointestinal organ system to be a 
common cause of death (Fleming et al., 2011), and in our study, gastric dilation volvulus 
accounted for 7 % of the causes of death, which actually is a higher proportion than joint disease 
(5 %).  
In our study we also found a high proportion of deaths due to pneumonia, which previously has 
not been presented in Swedish studies. However, a few other studies have shown an increased 
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incidence of pneumonia in the breed and also that several dogs affected by respiratory disease 
eventually were euthanized due to that cause (Clercx et al., 2003; Greenwell & Brain, 2014). 
Fleming et al. (2011) also presented respiratory disease to be one of the most common causes 
of death in North American Irish wolfhounds.  
Dilated cardiomyopathy 
Among the Swedish owners of Irish wolfhounds, DCM has attracted great attention because it 
is fatal, and insurance data has pointed out heart disease in the breed as a major cause of death 
(Egenvall et al., 2005). This may result in an interest to participate in this study, particularly 
owners or breeders of dogs having died from DCM or those highly committed to improve the 
general health situation in the breed are likely to respond to surveys like the present. However, 
a retrospective study like this will only identify dogs diagnosed with DCM, but not the dogs 
with preclinical DCM, unless they were examined by echocardiography. Brownlie and Cobb 
(1999) reported that 12 % of Irish wolfhounds without clinical sign of heart disease had atrial 
fibrillation (which is an indication of preclinical DCM), which means that the occurrence of 
DCM among the Irish wolfhounds may be higher than reported in the present study. When 
comparing the occurrence of DCM in this study population (16 %) one has to remember that in 
other studies with higher prevalence of DCM (24 %, 26 % and 43 %) dogs have been classified 
by an echocardiographic examination and preclinical cases are probably included (Vollmar, 
2000; Distl et al., 2007; Vollmar et al., 2013). On the other hand, four of the dogs classified to 
have DCM in this study, were not diagnosed by post mortem examination or echocardiography 
but were classified as probably affected or with suspicion of DCM by the author. Therefore, a 
few individuals may have been misdiagnosed concerning DCM. Nevertheless, this study 
supports the fact that DCM is common in the breed.  
When comparing the occurrence of DCM by year of birth, the disease seems to be more 
common among the dogs born 2006 and 2007 compared to 2008. This is most probable an 
effect of the lower response rate for dogs born in 2008 and therefore smaller sample size. 
Another possibility is that dogs born 2008 were younger (7 years old to current date) and had 
not yet developed DCM. However, studies have reported the mean age of being diagnosed with 
DCM to be 4-5 years (Vollmar, 2000; Distl et al., 2007; Philipp et al., 2012). The majority of 
the dogs born 2008 would therefore already have developed the disease if they had the 
predisposition. A third possibility is that the disease could be declining in incidence in the breed 
and further research may be warranted.  
The number of dogs with DCM in this study was small (16 dogs), but a difference in occurrence 
between sex was present, however this was not significant. A sex predisposition has been shown 
in a previous study where DCM in Irish wolfhounds was more common among males than 
females (Distl et al., 2007). The lack of a significant result in the present study may be due to 
the small sample size.  
Pneumonia 
Few studies have been published regarding pneumonia in Irish wolfhounds. These studies 
report that the incidence in the breed is high and respiratory disease is frequently reported as a 
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cause of death (Fleming et al., 2011; Greenwell & Brain, 2014). Our study showed that 37 % 
of the study population had a history of pneumonia on at least one occasion. The occurrence of 
pneumonia was nearly equally distributed among males and females, and the difference was 
not significant. These calculations were based on 89 dogs, which is a larger sample size than in 
a previous study by Greenwell and Brain (2014). In our study, fifty-five percent of the dogs 
with history of pneumonia had at least one recurrent episode. The combination of a comparably 
high number of dogs where the owner had reported recurrent episodes of pneumonia, and 
pneumonia as cause of death, suggest that respiratory disease is a serious problem in the breed. 
In this study, insufficient information was available to determine how the dogs had been 
diagnosed and how they had been treated. Questions were asked about course of treatment, time 
of recurrence and if full recovery was made, but these questions were often answered 
inadequately, and did not allow any further analysis. Greenwell and Brain (2014) found a 
predisposing cause for aspiration pneumonia in 44 % of the Irish wolfhounds. In our study, 
three of the dogs had megaesophagus, which may be suggestive as a predisposing cause for 
pneumonia. Only sixteen percent of the dogs (5 dogs) with history of pneumonia had also been 
diagnosed with DCM. Nevertheless, a possible association between pneumonia and DCM 
would be of interest to explore further in the future. The results from this study showed that 
more research is warranted regarding pneumonias in the breed, because little is known 
regarding etiology and predisposing factors.  
CONCLUSIONS 
The most common causes of death among the Irish wolfhounds participating in this study were 
tumors, heart disease and pneumonia. Occurrence of DCM in the studied population was 16 % 
and occurrence of pneumonia on at least one occasion was 37 %. These results support previous 
results from other studies that DCM and respiratory disease are common in the breed. DCM 
was more common in males than in females, but the difference was not significant. No sex 
predisposition was found regarding pneumonia. A high proportion of dogs with history of 
pneumonia had recurrent episodes. Because DCM and pneumonia also were reported as 
common causes of death, they should be given attention in the course of improving the general 
health in the breed. Further research regarding respiratory disease in the breed is warranted.  
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APPENDIX 1 
Survey 
- a health evaluation of Irish wolfhounds 
 
All information about You and Your dog will be treated confidentially 
 
Mandatory questions are marked with * 
 
Part 1 
 
Information about the dog 
Reg. no: * 
 
Breed: 
Irish wolfhound 
 
Registered name: * ID: chip and/or tattoo: 
 
  
The dog’s name: Date of birth: * 
 
 
Coat color: 
Sex * 
 
□   Male  
□   Female 
Neutered or spayed * 
 
□   Yes               Date:______________        
□   No 
 
Weight _____  kg       
□ Normal weight          □ Under normal weight          □ Overweight 
 
Has the dog been used for breeding? 
□   Yes           □   No                   
If Yes, how many offsprings does it have? ___________________________ 
 
Have relatives to the dog been diagnosed with dilated cardiomyopathy? 
(Parents, siblings and offspring are defined as relatives) 
□   Yes          □   No                   
If Yes, which? _________________________________________________                 
 
Owner 
First name: * 
 
Surname: * 
 
 
Country: * 
Street: * 
 
 
Postal code: * City: * 
e-mail: 
 
 
Telephone: 
 Home:      
 Cell phone: 
 Office: 
 
 
Continue to part 2 if the dog is DEAD or to part 3 if the dog is ALIVE 
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PART 2: The dogs is DEAD 
 
How did the dog die * 
Euthanasia ………………………….……… □ 
Spontaneously ……………..……………… □ 
Other………………………………………… □  
If Other, specify: ___________________________________________________ 
 
Date of death/euthanasia: *  _____________________ 
 
Cause of death * 
Dilated cardiomyopathy (congestive heart failure) ……… □ 
Other heart disease …………………………………….……... □ 
Bone cancer (osteosarcoma)……………..………………. □ 
Other tumor ………………………………………………. □ 
Pneumonia …….……………………………….…………. □ 
Joint disease …….………………………………………... □ 
Unknown cause ……………………….................................. □ 
Other …………………………………..……………………….. □  
If Other, specify: ___________________________________________________ 
 
The diagnosis was made by * 
Echocardiography ……………................…………………… □ 
Radiography ……………………………................................ □ 
Necropsy …………………………......................................... □ 
Unknown ……………………………..................................... □ 
Other …………………………………..……………………….. □ 
If Other, specify: ___________________________________________________ 
 
Was the dog diagnosed with dilated cardiomyopathy prior to death? * 
□  Yes □   No 
If Yes, approximate date: ___________________________________________ 
 
If Yes, did the dog receive any medical treatment due to heart disease? 
□   Yes □   No  
 
Specify which drugs: ________________________________________________ 
 
If your dog was diagnosed with dilated cardiomyopathy, did the veterinarian diagnose 
congestive heart failure (fluid in the lungs and/or abdomen)? 
□   Yes □   No   □   Don’t know 
 
Did the dog have clinical signs prior to death? * 
□  Yes  □   No 
If Yes, specify by checking below. 
 
Clinical signs 
Heart murmur ………………………………........................... □ 
Irregular heart rhythm/arrhythmia …………….…….………. □ 
If arrhythmia, specify which sort: ______________________________________ 
Fatigue …………….........................…………....................... □ 
Exercise intolerance ………………………………………...… □ 
Breathing difficulties ……………........……………………… □   
If breathing difficulties, describe breathing pattern: ________________________ 
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Cough ……………...................................................………. □ 
Abdominal distention ………..........………………………… □ 
Poor appetite ……………..............................…………….… □ 
Weight loss ……………...................................…………….. □ 
Other ……………......................................................……… □  
If Other, specify: ___________________________________________________ 
 
Was necropsy performed? * □   Yes  □   No  
 
Diagnosis from necropsy 
Dilated cardiomyopathy ………………………………..…..…. □ 
Tumor ……………................................................…............. □ 
Pneumonia …….……………………………………..……. □ 
Joint disease ………..................................................…......... □ 
Trauma …………...….....................................................…... □ 
Unknown ……………………………............................…….. □ 
Other ……………................................................................. □  
If Other, specify:    __________________________________________________ 
 
Has the dog ever been diagnosed with pneumonia? *  
□  Yes □   No  
If Yes, approximate date: ___________________________________________ 
 
How long was the dog treated for pneumonia?_____________________________ 
Did the dog recover?  □   Yes □   No 
 
Did the dog have pneumonia on more than one occasion? 
□  Yes  □   No 
If Yes, specify how many occasions and with approximate dates: ______________________ 
 
Have relatives to the dog been affected by pneumonia? * 
(Parents, siblings and offspring are defined as relatives) 
□   Yes          □   No                  If Yes, which? ____________________________          
 
Information about the veterinarian responsible for treatment 
 
Name of veterinarian: _______________________________________________ 
 
Name of veterinary clinic: ____________________________________________ 
 
Address: __________________________________________________________ 
 
Postal code, city and country: _________________________________________ 
 
Telephone: ________________________________  e-mail: _________________ 
 
Owner gives us (J. Häggström, I. Ljungvall, K. Höglund eller L. Orleifson) permission to access the 
dog’s case records: 
 
□   Yes   □   No 
 
Thank you for your participation! 
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PART 3: The dog is ALIVE 
 
 
Owner’s description of the dog * 
Healthy…………................................................................................................................... □ 
Dilated cardiomyopathy, untreated, no clinical signs from the heart …............................. □ 
Dilated cardiomyopathy, receiving medical treatment but have never had clinical signs  
from the heart…………………………………….…………………...……………….………….... □ 
Dilated cardiomyopathy, receiving medical treatment and have had clinical signs from  
the heart .... ……………………………………………….□ 
Other …………….................................................................................................................. □ 
If Other, specify: ___________________________________________________ 
 
Clinical signs 
Heart murmur ……………………………….......................... □ 
Irregular heart rhythm/arrhythmia ………………….……….□ 
If arrhythmia, specify which sort: ______________________________________ 
Fatigue …………….........................……………................... □ 
Exercise intolerance ……………………………………..…… □ 
Breathing difficulties ……………........…...………………… □   
If breathing difficulties, describe breathing pattern: ________________________ 
Cough ……………...................................................………. □ 
Abdominal distention …………….......……………………… □ 
Poor appetite ……………..............................…………….… □ 
Weight loss ……………...................................…………….. □ 
Other ……………......................................................……… □  
If Other, specify: ___________________________________________________ 
 
 
Veterinary examination has been performed *  
 
□   Yes  □   No  
 
Date: __________________________  
  
 
Information about the veterinarian responsible for treatment 
 
Name of veterinarian: _______________________________________________ 
 
Name of veterinary clinic: ____________________________________________ 
 
Address: __________________________________________________________ 
 
Postal code, city and country: _________________________________________ 
 
Telephone: ________________________________  e-mail: _________________ 
 
Owner gives us (J. Häggström, I. Ljungvall, K. Höglund eller L. Orleifson) permission to access the 
dog’s case records: 
 
□   Yes   □   No 
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Information from the veterinary examination 
 
Echocardiography has been performed *  
□   Yes □   No 
 
Diagnosis from the echocardiography examination 
Dilated cardiomyopathy ...................................................□ 
Congenital heart defect .....................................................□ 
Other heart disease ………………......................................□ 
Other..................................................................................□ 
If Other heart disease or Other, specify: _________________________________ 
 
Thoracic radiographs have been taken * 
□   Yes □   No 
 
Diagnosis from the radiography examination 
Pulmonary edema/fluid in the lungs................. □ 
Heart enlargement……………………………….. □ 
Pneumonia …………………………..…...…....….□ 
Other………………………………………...…..… □  
If Other, specify: ___________________________________________________ 
 
 
If your dog has been diagnosed with dilated cardiomyopathy, did the veterinarian diagnose 
congestive heart failure (fluid in the lungs and/or abdomen)? 
□   Yes □   No   □   Don’t know 
 
 
Does the dog receive any medical treatment due to heart disease? * 
□   Yes □   No  
 
Specify which drugs: ________________________________________________ 
 
When did the medical treatment start; date: ______________________________ 
 
 
Outcome of treatment 
No response ……………□ 
Improved ……………….□ 
Good response ………....□ 
Other ……………………□  
If Other, specify: ___________________________________________________ 
 
 
Has the dog ever been diagnosed with pneumonia? *  
□  Yes □   No  
If Yes, approximate date: __________________________________________ _ 
 
How long was the dog treated for pneumonia?_____________________________ 
Did the dog recover?  □   Yes □   No 
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Did the dog have pneumonia on more than one occasion? 
□  Yes  □   No 
If Yes, specify how many occasions and with approximate dates: ______________________ 
 
Have relatives to the dog been affected by pneumonia? * 
(Parents, siblings and offspring are defined as relatives) 
□   Yes          □   No                  If Yes, which? ____________________________             
 
 
Thank you for your participation! 
 
 
